Steven H Stein

CIK 1673776 · CMO & Head of Late-Stage Dev. · last filed 2026-05-20

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$8.50M

Companies

4

Total Filings

70

Lifetime Open-Market Net

-$24.88M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
INCY CMO & Head of Late-Stage Dev. 78,327 $108.53 $8.50M -$24.88M 59 2026-05-20
Repare Therapeutics Inc. (RPTX) Delisted Director $2.65 $0 1 2024-06-20
Theseus Pharmaceuticals, Inc. (THRX) Delisted Director $4.06 $0 3 2024-02-14
KURA Director $9.05 $0 7 2022-06-23

Recent Filings · Page 5 of 7

70 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2020-07-17 INCY Mixed −1,389 -$144.5K EDGAR
2020-07-08 INCY Mixed −3,893 -$653.1K EDGAR
2020-07-07 INCY Mixed +2,396 -$1.52M EDGAR
2020-06-26 KURA Grant (A) $0 EDGAR
2020-06-22 INCY Grant (A) +25,000 $0 EDGAR
2020-02-18 INCY Grant (A) +6,881 $0 EDGAR
2020-01-22 INCY Grant (A) $0 EDGAR
2019-10-31 INCY Grant (A) +50,000 $0 EDGAR
2019-07-16 INCY Tax (F) −409 -$33.3K EDGAR
2019-07-09 INCY Tax (F) −267 -$22.8K EDGAR
Showing 4150 of 70
Page 5 of 7
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.